APO-LEFLUNOMIDE leflunomide 20mg tablets bottle

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

leflunomide, Quantity: 20 mg

Dostępny od:

Arrotex Pharmaceuticals Pty Ltd

INN (International Nazwa):

Leflunomide

Forma farmaceutyczna:

Tablet, uncoated

Skład:

Excipient Ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone

Droga podania:

Oral

Sztuk w opakowaniu:

30 tablets

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Apo-Leflunomide is indicated for the treatment of active rheumatoid arthritis. The combined use of Apo-Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Podsumowanie produktu:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Licence status A

Data autoryzacji:

2011-07-22